NLRP3 and acute myocardial infarction: This observation led the authors to propose a cardioprotective role for the NLRP3 inflammasome in myocardial IRI, concluding that targeting NLRP3 or ASC may not be beneficial in the context of acute myocardial infarction and revascularization therapy [144].